19. November 2019

CUROLOX WHITENING Patent Granted In Key Regions

CUROLOX WHITENING has been invented by a collaborative project of the LMU Munich and credentis ag. Prof. Karl-Heinz Kunzelmann (LMU Munich), one of the leading experts in non-oxidizing tooth whitening collaborated with credentis to combine their know-how in tooth whitening with Hydroxyapatite and the CUROLOX® TECHNOLOGY to generate CUROLOX WHITENING.

CUROLOX WHITENING combines the high affinity of the CUROLOX-Biomatrix to tooth mineral with the light dispersion effect of sub-micro hydroxyapatite particles. The particles on the tooth surface cause teeth to appear whiter and brighter. The CUROLOX-Biomatrix ensures that the effect is imminent and visible for up to 4 weeks, as has been shown in a clinical trial published in the Clinical Journal of Dentistry (Bommer et al. 2018).

The CUROLOX WHITENING patent application has first been submitted in 2015 and has now been granted in all major regions – Europe, USA, China, Russia, Australia, South Africa and Singapore (additional regions are pending).

“In our research, we first investigated the whitening effect of hydroxyapatite alone. Through the additional combination with the CUROLOX TECHNOLOGY, we were able to bring the whitening effect into an optically appealing and more permanent form.” says Prof. Karl-Heinz Kunzelmann from the Department of Conservative Dentistry and Periodontology, University Hospital, LMU Munich.

23. May 2019

Credentis and DentaQuest Partner to Bring Innovative Cavity Prevention Products to US Markets

Direct Media Inquiries to:
Tom O’Rourke, Head of Corporate Communications
Thomas.orourke@greatdentalplans.com
(617) 886-1411

Boston, MA, May 23, 2019 – credentis, a leader in state-of the art oral biology research and development, and DentaQuest, the nation’s leading purpose-driven oral health care organization, have entered into a strategic partnership to test and promote Curodont™ Repair Fluoride Plus and other Curolox® products in the North American Market, enabling better pre-cavity treatment and prevention for US consumers. Through this collaboration, (more…)

16. May 2019

CURODONT REPAIR is the superior treatment for white spots

CURODONT REPAIR has shown to be superior to the gold-standard fluoride varnish in the treatment of initial caries as shown in a long-term, randomized, controlled clinical study. The new study conducted by Dr. Bröseler & Dr. Tietmann et. al. within their private practice, has recently been published in the prestigious journal Clinical Oral Investigations.

The clinical trial demonstrated significantly superior size reduction of the buccal white spot lesions after treatment with CURODONT REPAIR compared to those receiving fluoride varnish, which showed little change in size. In agreement with the size measurement, the researchers clinically assessed the white spots treated with CURODONT REPAIR to have regressed whereas control teeth were mainly unchanged, signifying the clinical benefit of the Guided Enamel Regeneration therapy with CURODONT REPAIR.

The strong Clinical Significance Statement by Dr Bröseler and co-workers highlights the potential of the novel regenerative therapy in caries prevention: “P11-4 [CURODONT REPAIR] is the first caries treatment approach aiming to regenerate decayed enamel. […] adding a new advanced therapy option for preventive dentistry.“

Visit the STRAUMANN booth at the 1st German Prevention Congress of the DGPZM this Friday and Saturday, 17th and 18th of May 2019 at the Hilton Düsseldorf and find out how your patients and your practice can benefit from this unique treatment.

Here for further information on CURODONT REPAIR and CURODONT REPAIR FLUORIDE PLUS (US version) or contact us directly.

11. April 2019

CURODONT REPAIR FLUORIDE PLUS – distribution starts in the US

Introducing CURODONT REPAIR FLUORIDE PLUS, a unique professional anti-cavity rinse for the non-invasive treatment of white spots. With the special CUROLOX formulation and application it acts where it is needed most, deep within the early carious lesion. Strengthening and remineralizing the entire enamel layer, it surpasses conventional fluoride products for anti-cavity treatment by far.

“We don’t have to imagine chemistry that literally grows into the tooth, now we have it!” Dr. Brian B. Nový, Director of Clinical Innovation, DentaQuest, Westborough, MA, USA.

Available now in the US through our partner Straumann, as a cornerstone in the new Straumann® Preventive Dentistry portfolio.

Get in contact and learn more in how to differentiate your practice, increase chair time value and diversify your patient base with this new therapy. Click here and register on Straumann’s dedicated website.

20. February 2019

CURODONT PROTECT – Best Prophylaxis during Orthodontic Treatment

CURODONT™ PROTECT shows superiority over fluoride varnish in caries prevention and remineralization of white spots around brackets.

(more…)

9. October 2018

credentis announces partnership with Straumann for CURODONT™ REPAIR

credentis disclosed today that it has signed a non-exclusive distribution agreement with  the Straumann Group for its non-invasive caries therapy CURODONT™ REPAIR. credentis’ unique product for Guided Enamel Regeneration will be launched as a key portfolio element for caries prevention and early caries treatment.

CURODONT REPAIR -Distributed by Straumann

(more…)

3. September 2018

Swiss university trial confirms superiority of CURODONT™ REPAIR in treatment of initial caries lesions

Curodot Repair in office

A randomized, placebo and gold-standard controlled clinical trial (RCT), investigating the treatment of incipient buccal caries lesions with CURODONT™ REPAIR was presented at the IADR 2018 in London. In this study Prof. Krejci and his team at the University of Geneva showed that the use of CURODONT™ REPAIR is superior to that of fluoride varnish (22’600ppm) or a placebo treatment.

(more…)

23. August 2018

Additional 15 years of IP protection for CURODONT™ REPAIR

Innovation is in our DNA!

While credentis goes new ways to prevent and treat caries, it is strong in the development of innovative medical devices and cosmetic solutions for the professional oral care market.

An additional patent for a “Method for producing a composition for treating a tooth lesion” has now been granted  in the US and the EU. With this credentis secures the intellectual property (IP) of the innovative CUROLOX® TECHNOLOGY in its leading caries treatment product CURODONT™ REPAIR for an additional 15 years.

A link to the patents: EU & US

22. May 2018

Dentin hypersensitivity: CURODONT™ D’SENZ shows faster desensitization than sensitivity toothpaste

In their study “Self-Assembling Peptide Matrix for treatment of dentin hypersensitivity: A randomized controlled clinical trial», Dr. M. Schlee and colleagues compared the ability of the CURODONT™ D’SENZ gel and a professional desensitizing toothpaste containing 8% arginine and calcium carbonate [ACC] to alleviate dentin hypersensitivity (DHS) over a period of 90 days.

(more…)

1. May 2018

credentis secures global distribution partner for CURODONT™ REPAIR

Credentis announced today that it has signed a non-exclusive distribution agreement with a global dental company for its unique non-invasive caries therapy CURODONT™ REPAIR. (more…)